Ion Beam Applications SA
SWB:IOB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ion Beam Applications SA
SWB:IOB
|
BE |
|
AL Sydbank A/S
CSE:ALSYDB
|
DK |
|
G
|
GFT Technologies SE
XBER:GFT
|
DE |
|
Morguard Corp
F:74S
|
CA |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
V
|
Vanda Pharmaceuticals Inc
F:VM4
|
US |
|
V
|
voestalpine AG
XMUN:VAS
|
AT |
|
A
|
Anglo American PLC
OTC:NGLOY
|
UK |
|
Biosig Technologies Inc
NASDAQ:STEX
|
US |
|
Daetwyler Holding AG
OTC:DATWY
|
CH |
|
Pharmagest Interactive SA
F:PHF
|
FR |
Wall St Price Targets
IOB Price Targets Summary
Ion Beam Applications SA
According to Wall Street analysts, the average 1-year price target for IOB is 15.26 EUR with a low forecast of 11.51 EUR and a high forecast of 18.45 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IOB's stock price target?
Price Target
15.26
EUR
According to Wall Street analysts, the average 1-year price target for IOB is 15.26 EUR with a low forecast of 11.51 EUR and a high forecast of 18.45 EUR.
What is the Revenue forecast for Ion Beam Applications SA?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Ion Beam Applications SA?
Projected CAGR
32%
Over the last 14 years, the compound annual growth rate for Operating Income has been 50%. The projected CAGR for the next 3 years is 32%.
What is the Net Income forecast for Ion Beam Applications SA?
Projected CAGR
51%
The compound annual growth rate for Net Income over the next 3 years is 51%.
